The Original BARK Company Common Stock BARK 深 滬
已收盤 08-01 16:00:00 美东时间
0.8444
-0.017
-1.97%
華盛通- 最 高0.8614
- 今 開0.85
- 成交量 109.81万股
- 最 低 0.8012
- 昨 收 0.8614
- 總市值 1.43亿
- 52周最高 2.555
- 市盈率 靜 --
- 換手率 0.65%
- 52周最低 0.77
- 委 比 -25.00%
- 總股本 1.69亿
- 歷史最高 19.54
- 量 比 1.50
- 振 幅 6.99%
- 歷史最低 0.701
- 每 手 1
- 風險率 0.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy
Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular dystrophy patients.
07-25 23:09
BARK receives non-compliance notice with NYSE listing standards
BARK (NYSE:BARK) said on Friday that the New York Stock Exchange has issued a notice on July 10, 2025, informing the company that it is no longer in compliance with its continued listing standards. Th...
07-12 04:13
Pfizer And Astellas Pharma Report Topline Results From OS Analysis From Phase 3 EMBARK Study Evaluating XTANDI, In Combination With Leuprolide And As Monotherapy, In Men With nmHSPC With High Risk BCR
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical recurrence (BCR)Pfizer
07-10 18:48
DMD基因治疗报道第二例死亡，直接诱因是？
6月15日，杜氏肌营养不良症（DMD）治疗先驱Sarepta再次更新了该公司已上市基因疗法ELEVIDYS（研发代码：SRP-9001）的安全信息。 ELEV...
06-16 12:50
Sidoti Events, LLC's Virtual June Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Sidoti Events, LLC, an affilia...
06-10 19:30
美股大行评级 | 潜在涨幅6326.33%！Ascendiant Capital上调Plus Therapeutics目标价至20.5美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1137665801621229569.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持Plus Therapeutics(PSTV)"买入"评级，目标价从20美元升至20.5美元</p> <p>• Ascendiant Capital：维持RenovoRx(RNXT
06-06 09:45
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Gainers Newegg Commerce (NASDAQ:NEGG) shares moved upwards by 64.0% to $10.3 d...
06-06 01:06
Canaccord Genuity Maintains Hold on BARK, Lowers Price Target to $2
Canaccord Genuity analyst Maria Ripps maintains BARK (NYSE:BARK) with a Hold and lowers the price target from $2.5 to $2.
06-05 21:38
Why MongoDB Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Shares of MongoDB, Inc. (NASDAQ:MDB) rose sharply in today's pre-market trading...
06-05 18:54
电话会总结 ｜ BARK Q4 2025 业绩电话会核心要点
<span> <meta content="no-referrer" name="referrer"></span><span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote> <p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• **财务业绩**： - BARK 在2025财年实现了首个全年正向调整后 EBITDA（非GAAP），全年调整后 EBITDA 为540万美元，其中第四季度为520万美元。 - 2025财年总营收为4.842亿美元，同比下降1.2%；第四季度营收为1.154亿美元。 - Commerce（商业）板块全年营收为6830万美元，同比增长27%，占公司总营收的14%，高于上一财年的11%。 - BARK Air 在2025财年创收近600万
06-05 12:05
